The 2021 OBIO Investment Summit national call for applications from health science companies that are seeking Series A or beyond investments is now open.

Guest User 7/21/20 Guest User 7/21/20

OBIO Announces First Eight Early Adopter Health Network Projects to Drive Innovation into the Health System

The Ontario Bioscience Innovation Organization (OBIO®), a not-for-profit organization dedicated to advancing health technology innovation and commercialization, is proud to announce the launch of the first eight Early Adopter Health Network (EAHN™) innovation projects.

Guest User 6/4/20 Guest User 6/4/20

OBIO’s Health to Business Bridge Program (H2BB) is Preparing the Future Leaders of Ontario’s Health Science Industry

OBIO’s Health to Business Bridge™ Program (H2BB) prepares new hires for careers in Ontario’s health science industry, helping companies build for the future in an innovative sector poised for growth.

Guest User 5/14/20 Guest User 5/14/20

OBIO Announces Early Adopter Health Network Call for Applications to Address COVID-19

This is a call to action for companies developing health technologies including COVID-19 management and treatment technologies to be evaluated for commercial readiness within its Early Adopter Health Network

Guest User 3/11/20 Guest User 3/11/20

OBIO launches first Early Adopter Health Network in Ontario

The Ontario Bioscience Innovation Organization (OBIO®), a not-for-profit organization dedicated to advancing health technology innovation and commercialization in Ontario, announce today’s launch of the province’s first-of-its-kind Early Adopter Health Network (EAHN). The EAHN is a network of health organizations that get leading-edge technologies into the health system.

Guest User 2/13/20 Guest User 2/13/20

Future of Health Care in Canada: OBIO Investment Summit Connects Global Investors, Leading-Edge Health Companies

Last week, 43 of the most promising companies in the Canadian health science industry came together at the OBIO Niagara Investment Summit, where they showcased their innovations to over 40 investors from across North America and Japan to pave the path to the investments needed to fully commercialize products.

Guest User 11/26/19 Guest User 11/26/19

2020 OBIO Capital Access Advisory Program - Call for Applications

2020 Call for Applications - NOW OPEN. OBIO CAAP® is a unique, industry-led initiative that provides selected high-potential Ontario health science companies with mentoring, strategic guidance and access to an expansive network of health science industry experts and investors to enhance the ability of OBIO CAAP companies to secure financing.

Guest User 8/27/19 Guest User 8/27/19

FedDev Ontario announces $6.24 million investment in OBIO

FedDev Ontario is investing up to $6.24 million for the Ontario Bioscience Innovation Organization (OBIO®) to boost investment, market access and mentorship opportunities for companies across southern Ontario looking to commercialize their medical innovations.